Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348)


Published in:
Leukemia, 28, 2, 404-407
Year:
2014
Publisher:
London, Nature Publishing Group
ISSN:
0887-6924
Note:
Letter
Laboratories:


Note: The status of this file is: Involved Laboratories Only


 Record created 2013-09-30, last modified 2018-03-17

Publisher's version:
Download fulltext
PDF

Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)